AKT inhibitor VIII
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-10355-5MG | 5 mg | 181,00 | Add | |
| HY-10355-1ML | 10mM/1mL | 217,00 | Add | |
| HY-10355-10MG | 10 mg | 254,00 | Add | |
| HY-10355-50MG | 50 mg | 710,00 | Add | |
| HY-10355-100MG | 100 mg | 1'100,00 | Add | |
| HY-10355-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
AKT inhibitor VIII (AKTi-1/2) is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2119 nM, respectively.
| Category | Inhibitor |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, Metabolic Disease, Apoptosis,PI3K/Akt/mTOR |
| Format | Solubility: DMSO : 20 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.97% |
| Molecular Formula | C34H29N7O |
| Molecular Weight | 551.64 |
| CAS-Number | 612847-09-3 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
